SIADH and other hyponatremic disorders: Diagnosis and therapeutic problems

Japanese Journal of Nephrology

Volumn 38, Issue 10, 1996, Pages 429-434

  Saito, Toshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

aged subjects; hyponatremia; mineral corticoid; non peptide ADH antagonist; SIADH

Indexed keywords

DESMOPRESSIN; FLUDROCORTISONE ACETATE; KALLIKREIN; MOZAVAPTAN; URIC ACID; VASOPRESSIN ANTAGONIST;

ADULT; AGE; AGED; DRUG STRUCTURE; HUMAN; HYPONATREMIA; ORAL DRUG ADMINISTRATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM METABOLISM; WATER DEPRIVATION;

BENZAZEPINES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; KALLIKREINS; RECEPTORS, VASOPRESSIN; URIC ACID;

EID: 0029861691     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Miller M, Morley JE, Rubenstein LZ: Hyponatremia in a nursing home population. J Am Geriatr Soc 43: 1410-1413, 1995
2. Sunderam SG, Mankikar GD: Hyponatremia in the elderly. Age Aging 12: 77-80, 1983
3. Ishikawa S, Fujita N, Fuijisawa G, Tsuboi Y, Sakuma N, Okada K, Saito T: Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatrerma in elderly patients. Endocrine J 43: 101-108, 1996
4. Helderman JH, Vestal RE, Rowe JW, Tobin JD, Andres R, Robertson GL: The response of arginine vasopressin to intravenous alcohol and hypertonic saline in man: The impact of aging. J Gerontol 33: 39-47, 1978
5. Zodik Z, Kowarski AA: Normal integrated concentration of aldosterone and plasma renin activity: Effect of age. J Clin Endocrinol Metab 50: 867-869, 1980
6. Saito, T: Guide for the diagnosis of SIADH. Annual report: Study Group of Japanese Minister of Health and Welfare about hypothalamo-pituitary disorders, p. 210, 1995. (in Japanese)
7. Robertson GL, Shelton RL, Athar S: The osmoregulation of vasopressin. Kidney Int 10: 25-37, 1976
8. Anderson RJ, Chung HM, Kluge R, Schrier RW: Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102: 165-168, 1985
9. Beck LH: Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301: 528-530, 1979
10. Tomita K, Shiigai T, Shichiri M, Andou R, Shinoda T, Takeuchi J: Increased urinary kallikrein-like activity in the syndrome of inappropriate secretion of antidiuretic hormone. Nephron 35: 39-48, 1983
11. Yamada K, Hasunuma K, Shina T, Ito K, Tamura Y, Yoshida S: Inter-relationship between urinary kallikrein-kinins and arginine vasopressin in man. Clin Sci 76: 13-18, 1989
12. Arieff AI: Central nervous system manifestations of disordered sodium metabolism. Clin Endocrinol Metab 13: 269-294, 1984
13. Ayus JC, Krothapalli RK, Arieff AI: Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Amer J Med 78: 897-902, 1985
14. Forrest JN, Cox M, Hong C, Morrison G, Bia M, Singer I: Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 298: 173-177, 1978
15. Fichman MP, Kleeman CR, Bethune JE: Inhibition of antidiuretic hormone secretion by diphenylhydantoin. Arch Neurol 22: 45-53, 1970
16. Ishikawa S, Saito T, Kaneko K, Okada K, Kuzuya T: Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury. Ann Int Med 106: 187-191, 1987
17. Oelkers W: Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321: 492-496, 1989
18. Manning M, Sawyer WH: Discovery, development, and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med 114: 617-632, 1989
19. Ohnishi A, Orita Y, Okahara R, Fujihara N, Inoue T, Yamamura Y, Yabuuchi Y, Tanaka T: Potent aquaretic agent: a novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in man. J Clin Invest 92: 2653-2659, 1993
20. Tsuboi Y, Ishikawa S, Fujisawa G, Okada K, Saito T: In vivo diuretic effect of a new nonpeptide arginine vasopressin antagonist, OPC-31260, in conscious rats. J Endocrinol 143: 227-234, 1994
21. Fujisawa G, Ishikawa S, Tsuboi Y, Okada K, Saito T: Therapeutic efficacy of nonpeptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44: 19-23, 1993
22. Tsuboi Y, Ishikawa S, Fujisawa G, Okada K, Saito T: Therapeutic efficacy of the nonpeptide AVP antagonist OPC-31260 in cirrhotic rats. Kidney Int 46: 237-244, 1994